90 related articles for article (PubMed ID: 26983777)
1. The 'SPARC' of life: Analysis of the role of osteonectin/SPARC in pancreatic cancer (Review).
Rossi MK; Gnanamony M; Gondi CS
Int J Oncol; 2016 May; 48(5):1765-71. PubMed ID: 26983777
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic cancer: Advances and challenges.
Halbrook CJ; Lyssiotis CA; Pasca di Magliano M; Maitra A
Cell; 2023 Apr; 186(8):1729-1754. PubMed ID: 37059070
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of SPARC in Patients with Pancreatic Cancer: A Systematic Review and Meta-Analysis.
Han W; Cao F; Chen MB; Lu RZ; Wang HB; Yu M; Shi CT; Ding HZ
PLoS One; 2016; 11(1):e0145803. PubMed ID: 26731428
[TBL] [Abstract][Full Text] [Related]
4. Targeting the Cancer-Neuronal Crosstalk in the Pancreatic Cancer Microenvironment.
Capodanno Y; Hirth M
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834436
[TBL] [Abstract][Full Text] [Related]
5. Citric acid promotes SPARC release in pancreatic cancer cells and inhibits the progression of pancreatic tumors in mice on a high-fat diet.
Xiao G; Wei Y; Xie R; Tsang Y; Gu J; Shen D; Ding M; Yuan J; Xu D; Fei J
FEBS J; 2024 Apr; 291(8):1699-1718. PubMed ID: 38245817
[TBL] [Abstract][Full Text] [Related]
6. Challenges in Recruitment and Retention: Leveraging Health-Related Antecedents and Information Carrier Factors to Improve Patient Participation in Pancreatic Cancer Research-A Review Article.
Coffin TB; Kenner BJ
Pancreas; 2022 Oct; 51(9):1074-1082. PubMed ID: 37078928
[TBL] [Abstract][Full Text] [Related]
7. The SPARC protein: an overview of its role in lung cancer and pulmonary fibrosis and its potential role in chronic airways disease.
Wong SL; Sukkar MB
Br J Pharmacol; 2017 Jan; 174(1):3-14. PubMed ID: 27759879
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of circulating osteonectin in patients with ischemic symptomatic chronic heart failure.
Berezin AE; Kremzer AA
Biomed J; 2015 Dec; 38(6):523-30. PubMed ID: 27013452
[TBL] [Abstract][Full Text] [Related]
9. SPOCK1 promotes metastasis in pancreatic cancer via NF-κB-dependent epithelial-mesenchymal transition by interacting with IκB-α.
Cui X; Wang Y; Lan W; Wang S; Cui Y; Zhang X; Lin Z; Piao J
Cell Oncol (Dordr); 2022 Feb; 45(1):69-84. PubMed ID: 34855159
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance and immune infiltration of microenvironment-related signatures in pancreatic cancer.
Lu Q; Zhang Y; Chen X; Gu W; Ji X; Chen Z
Medicine (Baltimore); 2021 Mar; 100(12):e24957. PubMed ID: 33761652
[TBL] [Abstract][Full Text] [Related]
11. SPOCK2 Affects the Biological Behavior of Endometrial Cancer Cells by Regulation of MT1-MMP and MMP2.
Ren F; Wang D; Wang Y; Chen P; Guo C
Reprod Sci; 2020 Jul; 27(7):1391-1399. PubMed ID: 32430715
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of SPOCK2 inhibits the invasion and migration of prostate cancer cells by regulating the MT1-MMP/MMP2 pathway.
Liu G; Ren F; Song Y
PeerJ; 2019; 7():e7163. PubMed ID: 31338255
[TBL] [Abstract][Full Text] [Related]
13. Tumour microenvironment of pancreatic cancer: immune landscape is dictated by molecular and histopathological features.
Karamitopoulou E
Br J Cancer; 2019 Jul; 121(1):5-14. PubMed ID: 31110329
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of SPARC Is Associated with Epithelial-Mesenchymal Transition and Low Differentiation State of Biliary Tract Cancer Cells.
Aghamaliyev U; Gaitantzi H; Thomas M; Simon-Keller K; Gaiser T; Marx A; Yagublu V; Araos J; Cai C; Valous NA; Halama N; Kiesslich T; Ebert M; Grützmann R; Rückert F; Breitkopf-Heinlein K
Eur Surg Res; 2019; 60(1-2):1-12. PubMed ID: 30650425
[TBL] [Abstract][Full Text] [Related]
15. Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets.
Nagy Á; Lánczky A; Menyhárt O; Győrffy B
Sci Rep; 2018 Jun; 8(1):9227. PubMed ID: 29907753
[TBL] [Abstract][Full Text] [Related]
16. International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017.
Isaji S; Mizuno S; Windsor JA; Bassi C; Fernández-Del Castillo C; Hackert T; Hayasaki A; Katz MHG; Kim SW; Kishiwada M; Kitagawa H; Michalski CW; Wolfgang CL
Pancreatology; 2018 Jan; 18(1):2-11. PubMed ID: 29191513
[TBL] [Abstract][Full Text] [Related]
17. Lack of Aberrant Methylation in an Adjacent Area of Left-Sided Colorectal Cancer.
Sambuudash O; Kim HS; Cho MY
Yonsei Med J; 2017 Jul; 58(4):749-755. PubMed ID: 28540987
[TBL] [Abstract][Full Text] [Related]
18. Cancer epigenetics comes of age.
Jones PA; Laird PW
Nat Genet; 1999 Feb; 21(2):163-7. PubMed ID: 9988266
[TBL] [Abstract][Full Text] [Related]
19. SPOCK2 gene expression is downregulated in pancreatic ductal adenocarcinoma cells and correlates with prognosis of patients with pancreatic cancer.
Aghamaliyev U; Su K; Weniger M; Koch D; D'Haese JG; Werner J; Bazhin AV
J Cancer Res Clin Oncol; 2023 Sep; 149(11):9191-9200. PubMed ID: 37188984
[TBL] [Abstract][Full Text] [Related]
20. Clinical Significance of Circulating Tumor Cell Induced Epithelial-Mesenchymal Transition in Patients with Metastatic Colorectal Cancer by Single-Cell RNA-Sequencing.
Kozuka M; Battaglin F; Jayachandran P; Wang J; Arai H; Soni S; Zhang W; Hirai M; Matsusaka S; Lenz HJ
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
